PacBio’s booth at AACR 2019 This month’s meeting of the American Association for Cancer Research (AACR) in Atlanta was a great showcase of the latest academic and translational research in this field. Years ago, the idea of analyzing cancer genomes played a niche role at the conference. Now, genomic and transcriptomic assessments are widely accepted as pivotal ways to understand cancer. This may have been best embodied by the organization’s choice for a new president: genome assembly pioneer Elaine Mardis. As usual, the PacBio team was out in force for the AACR conference. We attended talks, presented posters, and greeted…
We’re excited to be heading to Washington, DC, for the annual meeting of the American Association for Cancer Research. The PacBio team always enjoys hearing about the latest in cancer translational research at AACR, along with thousands of leading scientists in the field. Many of those scientists have already learned that SMRT Sequencing provides a unique view into cancer, revealing structural variation, phasing distant variants, and delivering full-length isoform sequences. With uniform coverage, industry-leading consensus accuracy, and reads extending to tens of kilobases, PacBio long-read sequencing gives researchers the ability to monitor and make sense of even the most complex…
The PacBio team headed to New Orleans this past April to take in all the exciting new research presented at the American Association for Cancer Research Annual Meeting, show off our new Sequel instrument, and of course enjoy some crawfish and beignets! On the first day of the conference, we had the pleasure of hearing a talk from last year’s AACR “What Will You Discover About Cancer?” SMRT Grant winners, Malgorzata Komor and Remond Fijneman from the Netherlands Cancer Institute. Malgorzata discussed her work to identify novel biomarkers to identify precursor lesions in colorectal cancer, which can be integrated into…
The PacBio team is gearing up for the annual meeting of the American Association for Cancer Research (AACR), which will be held April 16-20 in New Orleans. We’re looking forward to introducing the AACR community to the Sequel System, our new SMRT Sequencing platform that’s half the price and a third of the size of our PacBio RS II System. With 5-10 Gb of throughput per SMRT Cell, we think the Sequel System will be a great fit for the cancer research world. Presentations Sunday, April 17, 4:15 – 6:15 p.m., Room 243, Morial Convention Center MS.BSB01.01. Minisymposium: Novel…
We’re pleased to announce the winner of our recent “Most Interesting Genome in the World” grant competition. Congratulations to Jay Keasling and Jeff Wong at the University of California, Berkeley! The grant program, which was supported by co-sponsors Sage Science, Computomics, and the Arizona Genomics Institute, was very competitive with more than 250 submitted proposals. Keasling and Wong will be awarded SMRT® Sequencing — using up to 40 SMRT Cells with BluePippin™ DNA size selection — for Homalanthus nutans, a small rainforest tree that grows in Samoa. The plant is critical as the source of a natural product called prostratin,…
We’re looking forward to the annual meeting of the American Association for Cancer Research, which kicks off this weekend in Philadelphia. From directly phasing variants to sequencing full-length gene isoforms and other complex events, many scientists are already using SMRT® Sequencing to make exciting discoveries in cancer research. We hear from customers that the single-molecule approach opens the door for experiments they could not have done any other way. If you’ll be at AACR, we encourage you to attend the talk from UCSF’s Catherine Smith on Monday at 10:40 a.m. in room 201. Her presentation, “Polyclonal and heterogeneous resistance to…